Your Javascript appears to be disabled. In order to experience Universe, you need to turn your Javascript on.

The Cannabis Society: London Medical Cannabis Conference

Alphabeta Building

18 Finsbury Square, Finsbury, London EC2A 1BR, UK England

51.5215983 -0.08605820000002495

Description

The Cannabis Society is dedicated to fostering the cannabis community through events, conferences, dinners and much more. Join us together with doctors from both Europe and North America, industry experts, investors and licensed producers in the cannabis business for our incredible invite-only, executive-only style conference Medical Cannabis Conference. With the goal to educate and form strategic partnerships, the Medical Conference is a unique way to interact with North American doctors, European doctors and the global cannabis industry. The Cannabis Medical Conference is structured to include presentations from cannabis companies, followed by scheduled one-on-one meetings to be held between cannabis companies, North American doctors and European doctors (Meetings are scheduled in advance of the Conference). Attending and taking meetings with European doctors include executives of the largest licensed producers and North American doctors. The schedule is as follows: 2:00 PM - Registration 2:30 PM - Opening remarks by The Cannabis Society 2:40 PM - The North American Landscape with Canadian & US Doctors Panel 3:15 PM - The Current State of Cannabis Panel 3:45 PM - Patient Testimonials with Forzana Nasir 4:00 PM - Synergies between the UK and North America Panel 4: 30 PM - BREAK 4:45 PM - Keynote from Tom Zuber, Managing Partner at Zuber Lawler 5:00 PM - Regulatory Markets Panel 5:30 PM - Marketing in Cannabis Fireside Chat 6:00 PM - 7:00 PM Cocktails & Deal Making Confirmed Participants: Tom Zuber, Managing Partner of Zuber Lawler Tom Zuber has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. Tom holds a law degree from Columbia Law School, a master’s degree in public policy from Harvard Government School, and a biomedical engineering degree from Rutgers University, where he graduated with highest honors. David Badcock, CEO, Drug Science David Badcock has held strategic positions in the substance misuse treatment sector for over 15 years. During this time, he has met and worked with thousands of individuals who have turned their lives around to lead healthy, successful lives free from the burden of drug addiction. He was previously the Chief Executive Officer of Mainliners, a national treatment organization focusing on harm reduction and blood borne viruses, and also a senior manager at national drug treatment provider Addaction. In addition, David was a committee member for the Cambridge Ethnic Community Forum from 2002-2005, the chair of the Alliance (supporting people who receive prescribed medication for drug dependency) from 2007-2010, and scientific committee member for the influential London Joint Working Group for Substance Misuse and Hepatitis C from 2010-2015. David specializes in creating unique partnerships with organizations and companies who share a joint vision to help the most marginalized and vulnerable members of our communities. Dr. Jonas Vanderzwan, MD, CCFP Canadian physician with 15 years of primary care experience, and extensive experience in the use medical cannabis. As lead physician of a local cannabis clinic, he has been involved in the assessment and care of approximately 1500 patients, using cannabis as a treatment in a wide range of clinical conditions. As an early adopter of cannabis as a therapeutic agent, he has had the opportunity to travel the World, educating other medical professionals and patient groups on both the use and potential benefits of cannabis. Dr. Vanderzwan is an active consultant in the medical cannabis environment, having worked with both private and public players in the space, and since 2018 has been serving as Medical Director, and Chair of the Medical Advisory Board, for a Health Canada approved Licensed Producer of medical cannabis. In addition to ongoing membership in several international cannabinoid medicine organizations, Dr. Vanderzwan has most recently been appointed Vice-Chair of the Ontario Medical Association’s medical cannabis interest group. Dr. Andrea Burry, MSc, MD, CCFP Dr. Andrea Burry was the Medical Director of the Trauma Healing Center Cannabis Clinic since 2015. Dr. Burry completed her Bachelor of Science in Physiology and Psychology at the University of Western Ontario and both her Masters of Science and Medical Degree at the University of Toronto. She is a fellow of the Canadian College of Family Physicians and is an Associate with the Canadian Board of Occupational Medicine.Dr. Burry has an interest in medical cannabis and the role it can play in treating chronic pain and post-traumatic stress disorder. She is frequently called upon to speak or give an opinion on cannabis use in the workplace, particularly as it relates to safety sensitive roles. Dr. Burry currently divides her time between occupational medicine in both the public and private sector and clinical cannabis medicine and consulting. Dr. Adam Norris, MD, DABFM, CCFP Adam Norris has been working as a physician in Brantford, Ontario for the past 5 years.He completed his undergraduate studies at Dalhousie University in Neuroscience.Adam received his medical degree from Ross University and did a Family medicine residency at Northeastern University School of Medicine in Ohio. He is board certified in both Canada and the USA.Dr. Norris is a Family Physician and Medical Director of GreenDot Medical Center, Cannabinoid Clinic.He is currently Assistant Clinical Professor for Faculty of Family Medicine and Associate Professor at the MGD Centre for Medicinal Cannabis Research.This past year, he has taken a role as a consultant for Addiction Medicine at Brantford General Hospital. Professor Adam R Winstock MD Adam is a Consultant Addiction Psychiatrist and Addiction Medicine specialist based in London. He is Honorary Clinical Professor at the Institute of Epidemiolgy and Health Care, University College London. He is also founder and director of Global Drug Survey which runs the biggest drug survey in the world. He is also the architect of the free on line and smart phone apps the drugs meter www.drugsmeter.com and the world's first safer use cannabis guidelines at www.saferuselimits.co Michael Lynskey Professor of Addiction at the Institute of Psychiatry, Psychology & Neuroscience Michael is a Professor of Addiction at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London. Before moving to the UK, he held academic appointments in New Zealand, where he’s from, Australia and the United States. His research has focussed on the analysis of large, cross sectional, longitudinal and genetically informative data sets. Given rapid changes occurring in the regulation of cannabis use and supply, he is increasingly interested in studying policy approaches to cannabis and in the potential therapeutic benefits of cannabinoids. Dr. Dani Gordon MD CCFP ABOIM ABIHM Dr Dani is a double board certified medical doctor and leading expert in clinical cannabinoid medicine after treating 2500+ patients in Canada in a referral complex chronic disease practice where she specialized in neurological disorders, chronic pain and mental health conditions. She speaks internationally on cannabinoid medicine and in mid-2018 moved to London to train the UK’s first cannabis medicine specialist physicians, develop a leading online cannabis medicine physician training program, help setup the UK’s first cannabis medicine clinics and become the vice chair of the UK Medical Cannabis Clinicians Society (MCCS). She is an American Board Specialist in Integrative Medicine, the newest American sub-specialty of mainstream medicine, focused on the intersection of conventional and natural evidence-based medicine and therapeutics. Zulfigar Khan Co- Founder of CBD Consultants UK, (BSc, MSc PgD, MBA) Zulfiqar is the co-founder of CBD Consultants UK, a company, providing numerous services to the rapidly growing CBD sectors, in Europe and internationally, including; the farming of medical cannabis, licensing, clinical, regulatory, and investments. He is also the managing director of CBD Biotech Limited, a backbone for the new businesses and brands. During his career spanning over 23 years within Biopharmaceuticals, he has consistently sought challenging opportunities, launching and working on products that had a meaningful impact on the practice of medicine and ultimately on patient lives. With his precise expertise and interest within Oncology, currently, he is working closely with the World’s leading researchers and medics to envisage the possibility of setting up multicenter clinical studies with medical cannabis in various cancers, a highly understudied area, in spite of many anecdotes of its high effectiveness and miraculous cure. Zulfiqar has a science and business background, he holds a degree in pharmaceutical sciences, a postgraduate diploma from Hanze University in the Netherlands and an MBA from The Sheffield University, in England. Nick Pateras, Vice President, Strategy, Lift & Co. Nick Pateras is Vice President of Strategy at Lift & Co. (TSXV: LIFT), Canada's leading cannabis insights and education platform. Lift & Co.’s mission is to empower better cannabis decisions by bridging the informational gap between buyers and sellers. Prior to joining Lift & Co., Nick spent several years in the pharmaceutical sector with Johnson & Johnson Inc. His background in healthcare led him to make the professional move into cannabis, having long advocated for recognition of its many medical applications. Nick is a regular speaker at cannabis conferences across North America and Europe and teaches the Cannabis Business Fundamentals course at George Brown College. He holds two degrees, in Business and Philosophy, from Queen's University, Canada. Michael Fisher, Owner of Teeside Cannabis Club Despite starting life on the wrong side of the law, Michael battled his way through the impoverished estates of Teeside, to unleash his entrepreneurial streak. This first appeared in the form of a string of businesses in the local area before his father was unfortunately diagnosed with lung cancer. After witnessing first hand the medical benefits his late father derived from cannabis, and after treating his own Crohn’s disease with the plant, Michael became determined to challenge existing drug laws to ensure patients were no longer criminalized for the possession of cannabis. Since his father passing, Michael has been at the forefront of Medical cannabis activism opening his own Spanish style cannabis social club to develop the first cannabis social club model to be backed nationally by the police. Dr. Jan Halper-Hayes, PH. D. Dr. Jan Halper-Hayes is an internationally recognized expert in strategy, growth and change. She has built her career on creating speed and results in situations of change and ambiguity.As best-selling author and consultant, she works in partnership with Board of Directors and Senior Leadership Teams of FTSE 250, Fortune 500 and start-up companies to develop and implement strategies that encourage change and achieve sustained growth. Over the past 30 years, Jan Halper has done extensive work in M&A, with particular emphasis on restructuring companies, streamlining systems, advising senior executives – resulting in her clients becoming the leaders in their industry. As a renowned expert in mergers & acquisitions, Jan takes a top-down and bottom-up strategic approach. Jan served as the EMEA Leader for the Strategy and Change Practice at PwCC, subsequently acquired by IBM until 2007, Upon retiring from PwCC/IBM she launched Presage Advisory. Jan sought clients willing to pioneer innovative solutions using successful practices from behavioral intelligence and economics. Her clients have included: American Express, Unilever, Taylor Nelson Sofres, Toyota, T-Mobile, Aetna Insurance and Apple. September, 2013, Jan took a sabbatical as Managing Director of Presage Advisory, to serve as the Worldwide Vice President of Republicans Overseas; an organization that addresses policy issues that impact the 8.7 million overseas Americans. She built and led the 51 Country Chapters, built the FATCA legal action website and launched the first international straw poll. Simultaneously, she created a portal for overseas Americans voter registration: www.avotefromabroad.com. In 1988, THE TOM PETERS GROUP acquired JAN HALPER ASSOCIATES, a consulting firm specializing in management and marketing consulting, whose clients included:Lucasfilm, Ralston Purina, Gannett, IBM, Xerox, American Airlines, and Bank of America.Jan was the Management Expert for The Today Show and she worked in the Business News Department at KTVU-2 as a segment anchor, she presented biographical pieces on CEOs for ‘’Silicon Valley Business’’, and produced the nationally syndicated show, “On The Money.” Author of the international bestseller, “QUIET DESPERATION: The Truth About Successful Men”, a provocative study based on interviews with over 4,000 male executives and 43 in-depth profiles spanning over two years.Her book has been translated into 14 languages. Jan has appeared on:NBC Today Show, CNN News, CBS Morning Show, Geraldo, Oprah, CBS Nightwatch with Charlie Rose, ABC and CBS Radio Network.She has been written about in the Wall Street Journal, The London Times, USA Today, Christian Science Monitor, Washington Post and numerous local newspapers. In 1994, Jan Halper graduated from Stanford University Mass Media Institute’s Broadcast News Program.She did her doctorate work under Dr. Carl Rogers and Dr. Warren Bennis at Fordham University and then graduated from Columbia Pacific University with Ph.D. in Organizational Behavior & Psychology.Her undergraduate degree is from the State University of New York with an emphasis in Marketing and Human Relations. In 2017, Jan returned to participate in Stanford University’s Summer institute for Political Psychology. On a personal note, Jan Halper holds the title of California State Champion in Women’s Powerlifting for 1987 and 1988 and was ranked 13th in the United States until 1990.She frequently goes to France to work in the kitchen of the world-renowned chef Roger Verge. Emanuel Kotzian, CEO Agentur Sowjet GmbH For more than twenty years Emanuel Kotzian dedicates himself to the education about the effects of marihuana and lobbies for the re-normalization of this classic cultural plant. In 2000 he established Germany's biggest Cannabis-Magazine “Hanf Journal” and founded Agentur Sowjet GmbH, where he currently serves successful as its CEO. With more than 1 million fans, followers and readers on several channels, Agentur Sowjet is one of the leading marketing companies on the European Hemp Market. Its network of companies and branch offices extends from the Canary Islands to Kiev in the Ukraine and represents a unique platform for any market participant. Emanuel Kotzian was born 1972 in Krakow and immigrated with his family to Germany where he became a professing World-Citizen. After finishing High School in 1992 he studied Economics. Partly he was serving at a German court as a commercial judge, what did not stop him to get engaged into local politics. Now he is deeply involved in the promotion and up rise of CBD-Products, what he believes is a very important key for making hemp a normal and accepted natural product again." Dietwald Claus, Founder and CEO , Cannamerx Dietwald Claus is a public affairs professional with deep expertise in the Canadian food and agriculture regulatory system, as well crisis communications, standards development, and trade policy.He has worked for industry associations and consulting services since 2000. In 2016, Dietwald decided to combine his experience in dealing with highly regulated industries with his background in agricultural economics to create Cannamerx, the first fully automated B2B trading platform for the legal cannabis industry inCanada and internationally. Steve Rolles; Senior Policy Analyst for Transform Drug Policy Foundation, Steve Rolles is Senior Policy Analyst for Transform Drug Policy Foundation, a UK based think tank and charity focused on drug policy and law reform, where he has worked for over 20 years. Steve is extensively published on the subject of drug law reform and drug regulation, including 2014 'How to regulate cannabis; A practical guide.' He has served as an adviser for the Global Commission on Drugs, and the Uruguayan, Canadian, Mexican and New Zealand Governments in developing their cannabis regulation models. Avihu Tamir, Founder & CEO, Kanabo Research Avihu Tamir is a cannabis entrepreneur with over five years of hands-on experience in multiple Israeli medical cannabis ventures. He is the Founder and CEO of Kanabo Research, a medical cannabis R&D company based in Tel Aviv that focuses on building IP for inhaling medical cannabis, through vaporizer technology platforms and applications of patented cannabis formulations. Before starting Kanabo Research, Avihu was the founder of Teva Nature, the leading vaporizer company in Israel, and worked as a senior strategy consultant at Accenture. As a management consultant for many years, Avihu has vast experience in business strategy for major corporations, which he has used in many consulting projects for international cannabis ventures that touch on biotechnology, emerging agriculture and agtech, and other breakthrough technologies in the field of medical cannabis. Dr. Tom Chapman, QP, QPPV Tom is EU QP and QPPV with 58 years of experience within Pharmaceuticals and Biotech. Tom has a long history of researching, patenting and commercialising pharmaceutical, Biotech, and herbal products. During his distinguished career, he has successfully established, ran and then sold numerous businesses. Tom is also the lead investigator and innovator behind some landmark pharmaceutical and Biotech products and technologies, including, C02 extraction method, currently used for CBD extraction, Co-art-oral (Artemether, Lumefantrine) pediatric antimalarial drops. For many years Tom was a member of the British Pharmacopoeia herbal medicines committee creating monographs, which now appear in the European Pharmacopoeia. Tom has specialty and great interest in CBD and Cannabinoid research, currently he is actively involved and helping with Cannabis projects in Korea, Jamaica, UK , Lithuania, and New York State. Gold Partners: Sponsors:

This listing has no upcoming events

Start: 2019-06-24T14:00:00+01:00

End: 2019-06-24T19:00:00+01:00

Tickets

General Admission 99.0 GBP 40

Attendee Package 499.0 GBP 1